TE_59

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family SVA_D
TE superfamily SVA
TE class Retroposon
Gene ACOT7
Class Chimeric
Coding Non-coding
Tumor-specific score 1.89
Counts of samples TCGA_tumor:336; TCGA_normal:5; GTEx:195
TSS chr1(-):6306167



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_59.1 ACOT7 Chimeric Non-coding Non-coding chr1(-):6264675,6264695,6281102,6281286,6294864,6294980,6305464,6306168
teRNA_59.2 ACOT7 Chimeric Non-coding Non-coding chr1(-):6264675,6264695,6281102,6281286,6282724,6282796,6294864,6294980,6305464,6306168
teRNA_59.3 ACOT7 Chimeric Non-coding Non-coding chr1(-):6264675,6264695,6281102,6281286,6282724,6282888,6294864,6294980,6305464,6306168
teRNA_59.4 ACOT7 Chimeric Non-coding Non-coding chr1(-):6281266,6281286,6294864,6294980,6305464,6306168


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).